• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Iconic Therapeutics

edit

Iconic is a development-stage company, incorporated in December 2002 and currently based in Atlanta, Georgia. The Company is focused on the development and commercialization of novel immunoconjugate proteins called “I-cons™” which trigger the immune system to target and destroy unwanted cells in the body.

Milestones

edit

• 
  Iconic Therapeutics added Kirk Dornbush as Co-Founder, President and Chief Financial Officer.
  Posted 6/20/09 at 9:51pm
• 
  Iconic Therapeutics added Michael I. Sherman, Ph.D. as Co-Founder, and Chairman.
  Posted 6/20/09 at 9:51pm
• 
  Iconic Therapeutics received $2.5M in Series C funding. (1/17/09)
  Posted 6/20/09 at 9:54pm via bizjournals.com

Videos

Screenshots

edit

Above: Iconic Therapeutics Screenshot -- #1
Uploaded: 6/21/09

Sources

1. Iconic Therapeutics raises $2.5M from local angels and East Coast VC (networking.bizjournals.com) [edit]